Cochrane Funding Program 2026
Overview
Cochrane is an international, independent, not-for-profit organisation that aims to promote evidence-based practice in service provision and clinical healthcare. Cochrane systematic reviews are a key element in improving the quality and accessibility of the evidence to support healthcare decision making. The Australian Government has announced a total of $6,476,822 (GST exclusive) to support Cochrane activities in Australia over four years (from 1 July 2026 to 30 June 2030). This funding will be administered by the National Health and Medical Research Council (NHMRC).The objectives of this funding program are to:- Support Australian Cochrane review production and evidence synthesis to inform healthcare decision making.- Ensure that resources are allocated to specific, measurable activities that deliver high value outputs.For further information on the Cochrane Funding Program 2026, see the Cochrane Administered Funding Grant 2026-2030_grant opportunity guidelines. The activities that f
Eligibility Requirements
231013 - Medical Research
Who Can Apply
Relevant Industries
How to Apply
Applications are submitted through the official government portal. Review the eligibility criteria carefully before applying, and ensure all supporting documents are prepared.
Visit the official application page